Effect of Lactobacillus casei on the Production of Pro-Inflammatory Markers in Streptozotocin-Induced Diabetic Rats

Probiotics and Antimicrobial Proteins

Volumn 3, Issue 3-4, 2011, Pages 168-174

  Zarfeshani, A ^a   Khaza'ai, H ^a   Mohd Ali, R ^a   Hambali, Z ^b   Wahle, K W J ^c   Mutalib, M S A ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b Ministry of Higher Education   (Malaysia)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Diabetes mellitus; Inflammatory biomarkers; Lactobacillus casei Shirota; Probiotics

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; GLUCOSE; INTERLEUKIN 4; INTERLEUKIN 6; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; BODY WEIGHT; CONTROLLED STUDY; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HISTOLOGY; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS CASEI; LACTOBACILLUS SHIROTA; MALE; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES;

LACTOBACILLUS CASEI; MURINAE; RATTUS;

EID: 82555191053     PISSN: 18671306     EISSN: 18671314     Source Type: Journal    
DOI: 10.1007/s12602-011-9080-9     Document Type: Article

References (49)

1. Dunning T (2003) Care of people with diabetes: a manual of nursing practice. Wiley-Blackwell, Oxford.
2. Steinberg H, Brechtel G, Johnson A, Fineberg N, Baron A (1994) Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invest 94(3): 1172.
3. Zeng G, Quon M (1996) Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells. J Clin Invest 98(4): 894.
4. Aljada A, Ghanim H, Saadeh R, Dandona P (2001) Insulin inhibits NF {{kappa}} B and MCP-1 expression in human aortic endothelial cells. J Clin Endocrinol Metab 86(1): 450.
5. Dandona P, Chaudhuri A, Ghanim H, Mohanty P (2006) Proinflammatory effects of glucose and anti-inflammatory effect of insulin: relevance to cardiovascular disease. Am J Cardiol 99(4S): 15-26.
6. Dandona P (2002) Endothelium, inflammation, and diabetes. Curr Diabetes Rep 2(4): 311-315.
7. Malouf J, Kanagala R, Al Atawi F, Rosales A, Davison D, Murali N (2005) High sensitivity C-reactive protein A novel predictor for recurrence of atrial fibrillation after successful cardioversion. J Am Coll Cardiol 46(7): 1284-1287.
8. Ishida K, Kimura F, Imamaki M, Ishida A, Shimura H, Kohno H et al (2006) Relation of inflammatory cytokines to atrial fibrillation after off-pump coronary artery bypass grafting. Eur J Cardiothorac Surg 29(4): 501-505.
9. Crook M, Tutt P, Simpson H, Pickup J (1993) Serum sialic acid and acute phase proteins in type 1 and type 2 diabetes mellitus. Clinica Chimica Acta 219(1-2): 131-138.
10. Rodriguez-Moran M, Guerrero-Romero F (1999) Increased levels of C-reactive protein in noncontrolled type II diabetic subjects. J Diabetes Complicat 13(4): 211-215.
11. Jialal I, Devaraj S, Venugopal S (2004) C-reactive protein: risk marker or mediator in atherothrombosis? Hypertension 44(1): 6.
12. Wellen K, Hotamisligil G (2005) Inflammation, stress, and diabetes. J Clin Invest 115(5): 1111-1119.
13. Marnell L, Mold C, Du Clos T (2005) C-reactive protein: ligands, receptors and role in inflammation. Clin Immunol 117(2): 104-111.
14. Cho W, Yip T, Chung W, Leung A, Cheng C, Yue K (2006) Differential expression of proteins in kidney, eye, aorta, and serum of diabetic and non-diabetic rats. J Cell Biochem 99(1): 256-268.
15. Jain S, Rains J, Croad J (2007) Effect of chromium niacinate and chromium picolinate supplementation on lipid peroxidation, TNF-, IL-6, CRP, glycated hemoglobin, triglycerides, and cholesterol levels in blood of streptozotocin-treated diabetic rats. Free Radic Biol Med 43(8): 1124-1131.
16. Plein K, Hotz J (1993) Therapeutic effects of Saccharomyces boulardii on mild residual symptoms in a stable phase of Crohn's disease with special respect to chronic diarrhea-a pilot study. Z Gastroenterol 31: 129-134.
17. Thomas H, Parker J, Schreiber R, Kay T (1998) IFN-gamma action on pancreatic beta cells causes class I MHC upregulation but not diabetes. J Clin Invest 102(6): 1249.
18. Vellas BJ, Garry PJ (2001) Aging. In: Bowman BA, Russell RM (eds) Present knowledge in nutrition. ILSI, Washington, DC, pp 439-446.
19. Sartor R (2005) Probiotic therapy of intestinal inflammation and infections. Curr opin Gastroenterol 21(1): 44.
20. Erbaǧci AB, Tarakçioǧlu M, Coşkun Y, Sivasli E, Sibel NE (2001) Mediators of inflammation in children with type I diabetes mellitus: cytokines in type I diabetic children. Clin Biochem 34(8): 645-650.
21. Yadav H, Jain S, Sinha P (2007) Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats. Nutrition 23(1): 62-68.
22. Matsuzaki T, Yamazaki R, Hashimoto S, Yokokura T (1997) Antidiabetic effects of an oral administration of Lactobacillus casei in a non-insulin-dependent diabetes mellitus (NIDDM) model using KK-Ay mice. Endocr J 44(3): 357.
23. Matsuzaki T, Nagata Y, Kado S, Uchida K, Hashimoto S, Yokokura T (1997) Effect of oral administration of Lactobacillus casei on alloxan-induced diabetes in mice. APMIS 105(7-12): 637-642.
24. Tabuchi M, Ozaki M, Tamura A, Yamada N, Ishida T, Hosoda M et al (2003) Antidiabetic effect of Lactobacillus GG in streptozotocin-induced diabetic rats. Biosci Biotechnol Biochem 67(6): 1421-1424.
25. Cui H, Chen C, Wang J, Yang Y, Cun Y, Wu J (2004) Effects of probiotic on intestinal mucosa of patients with ulcerative colitis. World J Gastroenterol 10(10): 1521-1525.
26. O'Mahony L, Feeney M, O'Halloran S, Murphy L, Kiely B, Fitzgibbon J (2001) Probiotic impact on microbial flora, inflammation and tumour development in IL-10 knockout mice. Aliment Pharm Therap 15(8): 1219-1225.
27. Tanaka R, Ohwaki M (1994) Controlled study on the ingestion of Lactobacillus casei fermented milk on the intestinal microflora, its microbiology and immune system in healthy adults. In: Proceedings of the XII riken symposium on intestinal flora, Tokyo, Japan, pp 85-104.
28. De Preter V, Geboes K, Verbrugghe K, De Vuyst L, Vanhoutte T, Huys G (2004) The in vivo use of the stable isotope-labelled biomarkers lactose ureide and tyrosine to assess the effects of pro-and prebiotics on the intestinal flora of healthy human volunteers. Br J Nutr 92(3): 439-446.
29. Shioiri T, Yahagi K, Nakayama S, Asahara T, Yuki N, Kawakami K et al (2006) The effects of a synbiotic fermented milk beverage containing lactobacillus casei strain shirota and transgalactosylated oligosaccharides on defecation frequency, intestinal microflora, organic acid concentrations, and putrefactive metabolites of sub-optimal health state volunteers: a randomized placebo-controlled cross-over study. Biosci Microflora 25(4): 137-146.
30. Ohashi Y, Nakai S, Tsukamoto T, Masumori N, Akaza H, Miyanaga N et al (2002) Habitual intake of lactic acid bacteria and risk reduction of bladder cancer. Urol Int 68(4): 273-280.
31. Ishikawa H, Akedo I, Otani T, Suzuki T, Nakamura T, Takeyama I et al (2005) Randomized trial of dietary fiber and Lactobacillus casei administration for prevention of colorectal tumors. Int J Cancer 116(5): 762-767.
32. Souza M, Aguilar-Nascimento J, Dock-Nascimento D (2007) Effects of budesonide and probiotics enemas on the systemic inflammatory response of rats with experimental colitis. Acta Cirurgica Brasileira 22: 40-45.
33. Damaskos D, Kolios G (2008) Probiotics and prebiotics in inflammatory bowel disease: microflora 'on the scope'. Br J Clin Pharmacol 65(4): 453.
34. Raz I, Eldor R, Naparstek Y (2005) Immune modulation for prevention of type 1 diabetes mellitus. Trends Biotechnol 23(3): 128-134.
35. Kern P, Ranganathan S, Li C, Wood L, Ranganathan G (2001) Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 280(5): E745.
36. Singh U, Devaraj S, Jialal I (2005) Vitamin E, oxidative stress, and inflammation. Nutrition 25(1): 151-174.
37. Grunfeld C, Feingold K (1991) The metabolic effects of tumor necrosis factor and other cytokines. Biotherapy 3(2): 143-158.
38. Lfgren P, Naslund E, Reynisdottir S, van Harmelen V, Ryden M, Rssner S (2000) Secretion of tumor necrosis factor-alpha shows a strong relationship to insulin-stimulated glucose transport in human adipose tissue. Diabetes 49(5): 688.
39. Halse R, Pearson S, McCormack J, Yeaman S, Taylor R (2001) Effects of tumor necrosis factor- on insulin action in cultured human muscle cells. Diabetes 50(5): 1102.
40. Fernandez-Real J, Vayreda M, Richart C, Gutierrez C, Broch M, Vendrell J (2001) Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. J Clin Endocrinol Metab 86(3): 1154.
41. Baumann H, Gauldie J (1994) The acute phase response. Immunol Today 15(2): 74-80.
42. Hussain M, Peakman M, Gallati H, Lo S, Hawa M, Viberti G (1996) Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM. Diabetologia 39(1): 60-69.
43. Pickup J, Mattock M, Chusney G, Burt D (1997) NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 40(11): 1286-1292.
44. Pradhan A, Manson J, Rifai N, Buring J, Ridker P (2001) C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286(3): 327.
45. Spranger J, Kroke A, Mhlig M, Hoffmann K, Bergmann M, Ristow M (2003) Inflammatory cytokines and the risk to develop type 2 diabetes. Diabetes 52(3): 812.
46. Rapoport M, Jaramillo A, Zipris D, Lazarus A, Serrez D, Leiter E et al (1993) Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J Exp Med 178(1): 87.
47. Cameron M, Arreaza G, Zucker P, Chensue S, Strieter R, Chakrabarti S (1997) IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function. J Immunol 159(10): 4686.
48. Lee M, Koh J, Han S, Ko K, Kim S (2002) Prevention of autoimmune insulitis by delivery of interleukin-4 plasmid using a soluble and biodegradable polymeric carrier. Pharm Res 19(3): 246-249.
49. Kekkonen R, Kajasto E, Miettinen M, Veckman V, Korpela R, Julkunen I (2008) Probiotic Leuconostoc mesenteroides ssp. cremoris and Streptococcus thermophilus induce IL-12 and IFN- production. World J Gastroenterol: WJG 14(8): 1192.